Physician profile
Gregory C Johnson
NPI 1447396460
$1,155.10
in general payments reported to CMS, 2019-2025
9 companies · $50.25 in 2025
The $50.25 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.26 · 2020: $88.98 · 2021: $163 · 2022: $166 · 2023: $269 · 2024: $403 · 2025: $50.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $722.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $722.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $441.31 | 2020-2025 | Clareon, Tryptyr |
| Johnson & Johnson Vision Care, INC. | $422.02 | 2021-2024 | Acuvue |
| Amgen INC. | $125.00 | 2024 | Tepezza |
| Lilly USA, LLC | $53.00 | 2023-2025 | Taltz, Olumiant, Ebglyss |
| Janssen Biotech, INC. | $50.40 | 2023 | Tremfya |
| Alimera Sciences, INC. | $22.41 | 2020 | |
| Spark Therapeutics, INC. | $15.26 | 2019 | |
| Coopervision INC. | $13.04 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $12.66 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.